Efficacy and safety of anti-TNF therapy for inflammatory bowel disease (IBD) in liver transplant recipients for primary sclerosing cholangitis (PSC): a multicenter experience.

被引：0
|
作者：
Combes, R. [1 ]
Altwegg, R. [1 ]
Laharie, D. [2 ]
De Ledinghen, V. [2 ]
Radenne, S. [3 ]
Conti, F. [4 ]
Chazouilleres, O. [4 ]
Duvoux, C. [5 ]
Peyrin-Biroulet, L. [6 ]
Dumortier, J. [7 ]
Leroy, V. [8 ]
Treton, X. [9 ]
Durand, F. [9 ]
Dharancy, S. [10 ]
Nachury, M. [10 ]
Goutorbe, F. [11 ]
Lamblin, G. [11 ]
Pageaux, G. -P. [1 ]
机构：
[1] Univ Hosp St Eloi, Dept Hepatol & Gastroenterol, Montpellier, France
[2] Univ Hosp Bordeaux, Haut Leveque Hosp, Hepatogastroenterol, Bordeaux, France
[3] Hosp Civils Lyon, Croix Rousse, Hepatogastroenterol, Lyon, France
[4] Univ Hosp St Antoine, APHP, Hepatogastroenterol, Paris, France
[5] Univ Hosp Henri Mondor, APHP, Hepatogastroenterol, Creteil, France
[6] Univ Hosp Nancy, Gastroenterol, Nancy, France
[7] Hosp Civils Lyon, Edouard Heriot Hosp, Hepatogastroenterol, Lyon, France
[8] Univ Hosp Grenoble, Hepatogastroenterol, Grenoble, France
[9] Univ Hosp Beaujon, APHP, Gastroenterol, Clichy, France
[10] Univ Hosp Lille, Hepatogastroenterol, Lille, France
[11] Univ Hosp Clermont Ferrand, Hepatogastroenterol, Clermont Ferrand, France
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP033
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Anti-TNF Therapy for Inflammatory Bowel Disease (IBD) in Liver Transplant Recipients for Primary Sclerosing Cholangitis (PSC): A Multicenter Experience
    Combes, Roman
    Altwegg, Romain
    Laharie, David
    de Ledinghen, Victor
    Radenne, Sylvie
    Conti, Filomena
    Chazouilleres, Olivier
    Duvoux, Christophe
    Peyrin-Biroulet, Laurent
    Dumortier, Jerome
    Leroy, Vincent
    Treton, Xavier
    Durand, Francois
    Dharancy, Sebastien
    Nachury, Maria
    Goutorbe, Felix
    Lamblin, Geraldine
    Pageaux, Georges-Philippe
    GASTROENTEROLOGY, 2015, 148 (04) : S865 - S865
  • [2] SAFETY AND EFFICACY OF BIOLOGIC THERAPY FOR INFLAMMATORY BOWEL DISEASE IN LIVER TRANSPLANT RECIPIENTS FOR PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER EXPERIENCE
    Mousa, Omar Y.
    Tse, Chung Sang
    Sanchez, William
    Keaveny, Andrew Paul
    Kamath, Patrick S.
    Harnois, Denise M.
    Carey, Elizabeth J.
    Picco, Michael F.
    Loftus, Edward V.
    Leighton, Jonathan A.
    Lazaridis, Konstantinos N.
    Watt, Kymberly
    Eaton, John E.
    HEPATOLOGY, 2019, 70 : 702A - 703A
  • [3] Efficacy and safety of anti-TNF and vedolizumab in liver transplant recipients with inflammatory bowel disease (IBD)
    Bellanger, C.
    Beaugerie, L.
    Amiot, A.
    du Montcel, S. Tezenas
    Duvoux, C.
    Samuel, D.
    Carbonnel, F.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S343 - S344
  • [4] Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series
    Altwegg, Romain
    Combes, Roman
    Laharie, David
    De Ledinghen, Victor
    Radenne, Sylvie
    Conti, Filomena
    Chazouilleres, Olivier
    Duvoux, Christophe
    Dumortier, Jerome
    Leroy, Vincent
    Treton, Xavier
    Durand, Francois
    Dharancy, Sebastien
    Nachury, Maria
    Goutorbe, Felix
    Lamblin, Geraldine
    Boivineau, Lucile
    Peyrin-Biroulet, Laurent
    Pageaux, Georges-Philippe
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (07) : 668 - 674
  • [5] Screening primary sclerosing cholangitis (PSC) in patients with inflammatory bowel disease (IBD)
    Farkkila, M
    Karvonen, AL
    Pikkarainen, P
    Nurmi, H
    Nuutinen, H
    Karkkainen, P
    Mattila, J
    Taavitsainen, M
    Miettinen, A
    GUT, 1997, 41 : A178 - A178
  • [6] LACK OF EFFICACY OF INFLIXIMAB (IFX) IN THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS (PSC) IN INFLAMMATORY BOWEL DISEASE (IBD) IN CHILDHOOD
    Cardile, S.
    Candusso, M.
    Papadatou, B.
    Knafelz, D.
    Bracci, F.
    Pietrobattista, A.
    Liccardo, D.
    Torre, G.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E255 - E255
  • [7] A HISTORY OF INFLAMMATORY BOWEL DISEASE (IBD) IS ASSOCIATED WITH A REDUCED RISK OF REQUIRING LIVER TRANSPLANT AMONGST PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC)
    Ridout, Nicholas
    Huh, Alex
    Morrison, D. Alexander
    Daaboul, Yazan
    Karagozian, Raffi
    HEPATOLOGY, 2019, 70 : 792A - 792A
  • [8] Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis
    You Sun Kim
    Edward H. Hurley
    Yoojeong Park
    Sungjin Ko
    Experimental & Molecular Medicine, 2023, 55 : 1380 - 1387
  • [9] Colonoscopy Surveillance in Liver Transplant Recipients for Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease
    Rzadkowski, Stanislaw
    Chmielinska, Agnieszka
    Pacholczyk, Marek
    Lagiewska, Beata
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (08) : 2484 - 2486
  • [10] INFLAMMATORY BOWEL DISEASE (IBD) COMPLICATED BY PRIMARY SCLEROSING CHOLANGITIS (PSC) AND CIRRHOSIS - IS COLECTOMY SAFE?
    Lian, L.
    Kiran, P.
    Shen, B.
    Vogel, J.
    Remzi, F.
    DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 604 - 604
12345